Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks IPOs and placings
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Life Science REIT inks big lease at Oxford Technology Park
(Sharecast News) - Life Science REIT announced the full occupancy of building five at Oxford Technology Park (OTP) on Tuesday, encompassing 57,000 square feet, by technology and engineering services provider WAE Technologies. The London-listed company said the building , recently completed and poised to attain a BREEAM Excellent certification, was leased to WAE for a ten-year term, at an annual rent of £1,146,000, translating to £20.10 per square foot.
It said the lease incorporated a break clause at the halfway mark and a rent review at the end of the fifth year.
Life Science REIT said WAE Technologies is a subsidiary of Fortescue, a publicly listed Australian entity, operates within diverse sectors such as green energy, medical engineering, and automotive.
Fortescue also manages the Foresight WAE Technology Fund, which supports a spectrum of businesses, including ventures originating from prestigious academic institutions like Oxford and Cambridge Universities.
Among those ventures was Refeyn, specialising in molecular mass measurement, and ZOMP, renowned for its 3D whole-cell imaging technology.
The company said the occupied space within building five had been tailored to accommodate offices and research and development facilities to suit the specific requirements of WAE Technologies.
"OTP's combination of flexible, affordable, and best in class space as well as its proximity to leading, global life sciences institutions is compelling for a wide range of occupiers," said Ian Harris, director of asset management at the company's investment adviser, Ironstone Asset Management.
"WAE will be the largest occupier at OTP and its presence is a major step forward in delivering a vibrant and collaborative community at OTP."
At 0835 GMT, shares in Life Science REIT were up 1.55% at 52.4p.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity and Inclusion | Doing Business with Fidelity | Fidelity gender pay report | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
